Sectors
DFTX
Mind Medicine (MindMed) Inc.
44.32
2 x 44.30
2 x 44.41
bid
ask
-
0.76
1.69%
10:00 AM
timesize
| Ytd | 188.17% | |
| 1y | 188.17% |
43.89
day range
44.99
12.88
52 week range
49.20
| Open | 44.02 | Prev Close | 45.08 | Low | 43.89 | High | 44.99 | Mkt Cap | 4.92B |
| Vol | 100.81K | Avg Vol | 4.53M | EPS | N/A | P/E | N/A | Forward P/E | -32.07 |
| Beta | 2.20 | Short Ratio | 5.00 | Inst. Own | 66.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 14.26 | 200-d Avg | 14.26 | 1yr Est | 57.80 |
| Income Statement | |||
| Operating Expenses | 59.22M | ||
| Research and Development Expense | 41.48M | ||
| Selling, General and Administrative Expense | 17.74M | ||
| Operating Income | -59.22M | ||
| Interest Expense | 1.25M | ||
| Net Income | -77.10M | ||
| Net Income Common Stock | -77.10M | ||
| Net Income Common Stock (USD) | -77.10M | ||
| Consolidated Income | -77.10M | ||
| Earnings per Basic Share | -0.71 | ||
| Earnings per Basic Share (USD) | -0.71 | ||
| Earnings per Diluted Share | -0.71 | ||
| Earning Before Interest & Taxes (EBIT) | -75.85M | ||
| Earning Before Interest & Taxes (USD) | -75.85M | ||
| Weighted Average Shares | 108.79M | ||
| Weighted Average Shares Diluted | 108.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 262.52M | ||
| Cash and Equivalents (USD) | 262.52M | ||
| Investments | 110.90M | ||
| Investments Current | 110.90M | ||
| Current Assets | 380.56M | ||
| Total Assets | 401.29M | ||
| Total Debt | 40.77M | ||
| Current Liabilities | 81.11M | ||
| Debt Non-Current | 40.77M | ||
| Total Liabilities | 122.44M | ||
| Accumulated Retained Earnings (Deficit) | -659.77M | ||
| Accumulated Other Comprehensive Income | 824.00K | ||
| Shareholders Equity | 278.85M | ||
| Shareholders Equity (USD) | 278.85M | ||
| Assets Non-Current | 20.73M | ||
| Total Debt (USD) | 40.77M | ||
| Goodwill and Intangible Assets | 19.92M | ||
| Liabilities Non-Current | 41.33M | ||
| Trade and Non-Trade Payables | 7.13M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 5.31M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.68M | ||
| Issuance (Purchase) of Equity Shares | 1.47M | ||
| Net Cash Flow from Investing | 42.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 42.00M | ||
| Net Cash Flow from Operations | -42.63M | ||
| Effect of Exchange Rate Changes on Cash | 3.00K | ||
| Share Based Compensation | 7.13M | ||